AU Patent

AU2012203953A1 — Stilbene derivatives and their use for binding and imaging amyloid plaques

Assigned to University of Pennsylvania Penn · Expires 2012-07-26 · 14y expired

What this patent protects

C-\.qRPorbl\DCLRBR\4499M2_1 DOC-5)07/2012 This invention relates to a method of imaging amyloid deposits and to labeled compounds, and methods of making labeled compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds…

USPTO Abstract

C-\.qRPorbl\DCLRBR\4499M2_1 DOC-5)07/2012 This invention relates to a method of imaging amyloid deposits and to labeled compounds, and methods of making labeled compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits. C) OCn 00 c LnC ~ X SUBSTITUTE SHEET (RULE 26)

Drugs covered by this patent

Patent Metadata

Patent number
AU2012203953A1
Jurisdiction
AU
Classification
Expires
2012-07-26
Drug substance claim
No
Drug product claim
No
Assignee
University of Pennsylvania Penn
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.